3D Printing in Healthcare Market Growth Accelerated by Medical Modelling and Personalized Healthcare
3D printing in healthcare, also known as medical additive manufacturing, utilizes 3D printing technology to produce medical devices andparts, surgical instruments, hearing aids, and more personalized healthcare products. 3Dprinting offers huge advantages over traditional manufacturing processes as it enablesmass customization by creating highly accurate and customized medical products suited toindividual patients' needs. The global 3D Printing in Healthcare Market is estimated to be valued at US$ 2.21 Bn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Medical modelling and personalized healthcare have emerged as one of the key trends driving the growth of the 3D printing in healthcare market.3D printing technology enables doctors and surgeons to create accurate anatomical models using medical scans of patients which helps in pre-operative planning and complex surgery simulation. This greatly improves surgical outcomes and reduces risks involved. It also enables creating customized implants, prosthetics and other devices precisely matching patients' body and anatomy which offers superior comfort and functioning compared to standardized products. As this technology facilitates customized and personalized healthcare by leveraging patients' medical scans and data, its adoption is increasing steadily across hospitals and clinics globally.
Segment Analysis
The global 3D printing in healthcare market is dominated by the medical devices sub-segment which accounts for over 35% of the market share. 3D printing in medical devices has revolutionized the production of various implantable medical devices such as dental crowns, surgical guides, prosthetics, and hearing aids. The personalized precise design capabilities of 3D printing technologies allow for a better fit and comfort for patients. 3D printed medical devices have superior biocompatibility and are less prone to rejection by the human body.
Key Takeaways
The global 3D Printing In Healthcare Market Share is expected to witness high growth over the forecast period of 2023 to 2030 supported by the increasing prevalence of chronic diseases worldwide.
Regional analysis: North America currently dominates the global 3D printing in healthcare market accounting for over 40% share driven by the advanced healthcare infrastructure and higher adoption of new technologies in the region. Asia Pacific is expected to be the fastest growing regional market over the forecast period supported by improving access to healthcare and presence of emerging economies like India and China with high patient pools.
Key players operating in the 3D printing in healthcare market are Stallergenes Greer PLC, Sanofi SA, Novartis International AG, Dermapharm Holding SE, Leti Pharma, Johnson & Johnson, GlaxoSmithKline PLC, Nicox SA, F. Hoffmann-La Roche Ltd., Allergy Therapeutics PLC, AbbVie Inc. (Allergan), Bausch Health Companies Inc., Teva Pharmaceutical Industries, ALK-Abello AS, and Alembic Pharmaceuticals Limited, among others. Stallergenes Greer PLC specializes in allergen immunotherapy therapeutic vaccines for treatment of allergic rhinitis and asthma.
Comments
0 comment